EUVIMED · CrossrefJournal
Oncology in Clinical Practice
ISSN 2450-1654 · VM Media Group sp. z o.o
Latest articles
Locally advanced thoracic NUT carcinoma — a case report and literature review
Development and validation of a mobile application assisting oncologists with prescribing appropriate thromboprophylaxis for ambulatory cancer patients with high risk of thromboembolism — a pilot study
Oral mucositis pain management — an overview of current guidelines and clinical approaches
Nanoparticles in targeted breast cancer therapy — advances and challenges
Top 100 most cited articles on cyclin-dependent kinase 4/6 inhibitors — a bibliometric and altmetric analysis
The use of stereotactic radiotherapy in the treatment of lung malignancies — a scoping review
Unveiling the role of atezolizumab in non-small cell lung cancer and coexisting chronic obstructive pulmonary disease — a comprehensive review
Lung adenocarcinoma metastatic to the paranasal sinuses — hypotheses on tumor spread and considerations on the role of radiotherapy
An 80-year-old female with pseudomyxoma peritonei due to mucinous cancer of unknown origin — molecular characterization and diagnostic challenges
Comparative validation of prognostic indices in brain metastases receiving cranial radiotherapy
Predictors of oral mucositis and dysgeusia in breast cancer patients receiving FEC chemotherapy — a retrospective observational study
Risk of glioma malignant progression after biopsy-induced oncotaxis — a systematic review
Do we need to use neoadjuvant carboplatin in all patients with triple-negative breast cancer?
Pulmonary dendritic histiocytic sarcoma masquerading as massive pleural effusion: a case report on diagnostic challenge with poor prognosis
Unusual co-expression of nuclear OLIG2 and nucleolar H3K27me3 in a metastatic desmoplastic/nodular medulloblastoma: insights into an alternative biological interpretation
Acute and late toxicity after moderate hypo-fractionated intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) for prostate cancer
The role of vorasidenib, a dual inhibitor of the mutant IDH1 and IDH2 enzymes, in the treatment of diffuse adult-type gliomas
A review of expenditure, outcomes, access to oncology medicines and oncology health systems in ten European countries
Pediatric anaplastic ependymoma — intraoperative cytology and histopathological grading roles in the morpho-molecular era
Out-of-pocket (OOP) costs incurred by breast cancer patients in Poland
Cancer prevalence as a measure of cancer burden — Poland in the European context
Capivasertib — a new agent in the treatment algorithm for patients with advanced, metastatic HR-positive, HER2-negative breast cancer harboring genetic alterations in the PIK3CA/AKT1/PTEN genes
Experts’ position paper on the diagnostics of the PI3K–AKT–mTOR signaling pathway in hormone-dependent breast cancer
The sea that holds me: psychological outcomes of a sailing-based intervention in women with a history of cancer
Dynamic HER2 discordance in breast cancer with contralateral axillary metastasis: a case report and review of the literature
The role of NTRK gene fusions in the biology and treatment of solid tumors
Survival outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab: a comparison between ECOG performance status 0–1 and 2
Radiotherapy of head and neck cancer using volumetric modulated arc therapy (VMAT): a dosimetric and clinical comparison of moderately hypofractionated versus standard fractionation
Complications of neuro-oncological treatment: neurological, endocrine, and systemic adverse effects
First real-world experience with first-line pembrolizumab and chemotherapy treatment for advanced triple-negative breast cancer in Poland: safety analysis and first survival outcomes from a multicenter cohort
EUVIMED